Users of this system, can login to view this document.
Login
Enter the following information to request a copy of the document from the responsible person.
Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy.
This email address is used for sending the document.